Free Newsletter
Top-ranked woman to retire from J&J
There's another big executive departure coming in the world of Big Pharma: this time it's Christine Poon (photo), vice chairman of Johnson & Johnson and worldwide chair of its pharmaceuticals division. Poon, 56, plans to retire on March 1, J&J announced today, saying that it will announce a succession plan "in a timely fashion."
With 20 years in pharma, 15 of them at Bristol-Myers Squibb before she joined J&J, Poon has been a heavyweight in the industry. She's the top-ranked woman in the drug business, and, according to Forbes, one of the most respected. The magazine ranked her as the 26th most powerful woman in business in 2006.
- see J&J's release
- read the Forbes article
- get more from Pharmalot
Related Article:
J&J reorg anoints growth czar
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





